Cancer Research UK offers the following funding schemes for translational research.
Schemes are considered by either the Biomarkers and Imaging Discovery and Development Committee (BIDD), the Discovery Committee (DC) or the New Agents Committee (NAC).
Biomarkers and Imaging Discovery and Development (BIDD) Project Grants
BIDD Project Grants scheme funds research in all types of biomarkers using invasive and non-invasive technologies.
More information about this scheme...
Discovery Committee (DC) Grants
Discovery Committee Grants is the sole Cancer Research UK scheme operating for managed development of projects arising from the Charity's basic research portfolio.
More information about this scheme...
New Agents Committee (NAC) Trials Funding
The New Agents Committee (NAC) selects new anti-cancer treatments, funds any outstanding preclinical steps, and takes them into early clinical trials managed and sponsored by Cancer Research UK's Drug Development Office (DDO).
More information about this scheme...
